Catalyst Wire Dossier Catalyst Wire Dossier

Bevasiranib

· OPKO Health, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Bevasiranib, covering 2011-12-13 to 2015-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON) [Phase 3]

See pricing